GLP-1 TV · Clinician
MOUNJARO: All Your Questions Answered!
Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this short update, the speaker says Mounjaro (generic name tirzepatide) is approved for diabetes treatment and also causes weight loss. She says she expects it to be approved specifically for weight loss in the coming months. She describes it as similar to semaglutide, which she calls her favorite GLP-1 agonist and which is sold as Ozempic or Wegovy. According to her, Mounjaro also contains a GIP agonist, a drug class that stands for glucose dependent insulinotropic polypeptide.
Published by Christy Risinger, MD on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
The doctor says Mounjaro lowers hemoglobin A1c, a three-month average of blood sugars, by about 2.3 percent. She says it leads to about 10 pounds more weight loss than semaglutide. She explains that it is a once-weekly injection that works by stimulating insulin release, helping people feel full for longer and decreasing glucose production by the body. She adds that semaglutide-type drugs have been shown to lower risks such as heart attack and stroke, but she says data for Mounjaro on this will not be out until 2025 because the drug is so new.
She also says patients regain weight when these injections are stopped, which she says is true for Ozempic, Wegovy and probably Mounjaro. Her explanation is that the drugs act like hormones the stomach makes in response to food, and that these may be underproduced in people who struggle with weight. On access, she says there has been a supply shortage and that the cost is about $1,000 a month without insurance coverage. She says insurance will not cover it for weight loss alone at this point, and suggests asking a company's human resource manager to consider opting in for weight loss medication coverage.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:00 The speaker says Mounjaro (tirzepatide) is approved for diabetes and that she expects a weight loss approval in the coming months.
- 0:30 She says Mounjaro adds a GIP agonist to a GLP-1 agonist, lowers hemoglobin A1c by about 2.3 percent and produces about 10 pounds more weight loss than semaglutide.
- 1:01 She explains it is a once-weekly injection and says its cardiovascular data will not be out until 2025.
- 1:33 According to the doctor, patients gain the weight back when these injections are stopped, which she links to the body's hormone signals.
- 2:03 She says supply has been short and the cost is about $1,000 a month without insurance coverage, and that weight loss alone is not covered at this point.
- 2:33 She suggests asking your company's human resource manager to consider opting in for weight loss medication coverage.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Mounjaro
Questions this video answers
How much more weight loss does Mounjaro cause than semaglutide?
The speaker says Mounjaro leads to about 10 pounds more weight loss than semaglutide. She also says it lowers hemoglobin A1c by about 2.3 percent.
How much does Mounjaro cost without insurance?
According to the video, Mounjaro costs about $1,000 a month if insurance does not cover it. She also says there has been a supply shortage and that insurance will not cover it for weight loss alone at this point.
Do you regain weight after stopping Mounjaro?
The doctor says patients gain weight back when these injectable medications are stopped, which she calls true for Ozempic and Wegovy and probably Mounjaro. She explains that the drugs act like hormones that signal the brain about eating, so those signals are lost when treatment stops.
What can I do if my insurance does not cover weight loss medication?
The speaker suggests calling the human resource manager at your company and asking them to consider opting in for coverage of weight loss medications. She says the coverage change has to happen at the company providing the health insurance.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
The Real Reason Mounjaro Works (It's Not What You Think)In this video, the speaker, an obesity expert, gives an overview of Mounjaro (tirzepatide) for people who have been prescribed it or are thinking of asking a doctor about it.- Already on tirzepatide? What your next month costs at every programToday’s lowest is $69/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
MOUNJARO (Tirzepatide) | What to Know Before Starting!In this video, the speaker, D.O., gives an overview of Mounjaro (tirzepatide) for people considering it for type 2 diabetes.
Mounjaro (tirzepatide)... How does it work?In this talk, the speaker, an endocrinologist in Austin, Texas, explains Mounjaro (tirzepatide) from Eli Lilly.
Ozempic, Mounjaro & GPL-1 Agonists for Weight Loss | Dr. Zachary Knight & Dr. Andrew HubermanIn this clip, the speaker and another speaker discuss GLP-1 agonist drugs for weight loss.
Mounjaro Approved For Weight Loss But Doctors Warn Against Side EffectsThis Health Boost segment covers the US FDA approval of Mounjaro for obesity.
Diabetes drug Mounjaro shows heart benefits: StudyIn this segment, ABC News medical correspondent the speaker discusses a new study of Mounjaro, a diabetes drug.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- Mounjaro vs Ozempic, and the trial everyone quotes about it
Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.
- How to get Mounjaro: the diabetes route, and why the weight route is a different box
Mounjaro is approved for type 2 diabetes in adults and children from 10, and Lilly's own site says it is not a weight-loss drug. With a diabetes diagnosis, any prescriber can write it and a commercial plan that covers it brings it to $25 with Lilly's card. Without diabetes, a prescriber can write it off-label, but no insurer will cover it and LillyDirect self-pay starts at $499 a month, against a list price of $1,112.16 per fill. The same tirzepatide in the Zepbound box is approved for weight, plan-coverable, and sold direct for $299 to $699.
Next steps
Mounjaro prices
Find more like it
Cost and insuranceStopping and maintenance
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















